Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (271-280 of 325) with videos related to

Pageof 33
Sort By:
Blood Cancer Journal|February 5, 2025
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestryCecilia Bonolo de Campos, Chantal E McCabe, Laura A Bruins, et al.
Blood|July 4, 2013
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemiaAlessandra Ferrajoli, Tait D Shanafelt, Cristina Ivan, et al.
Blood|January 12, 2022
Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinibNoelia Purroy, Yuzhou Evelyn Tong, Camilla K Lemvigh, et al.
Blood|October 7, 2020
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapyNikolaos Ioannou, Patrick R Hagner, Matt Stokes, et al.
Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.
Leukemia|April 4, 2024
IκBε deficiency accelerates disease development in chronic lymphocytic leukemiaJessica Bordini, Chiara Lenzi, Michela Frenquelli, et al.
Blood|April 15, 2022
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trialTait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, et al.
The Lancet. Haematology|May 22, 2019
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validationsJacob D Soumerai, Ai Ni, Mohamed Darif, et al.
Blood|November 23, 2018
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenograftsRosalie M Sterner, Reona Sakemura, Michelle J Cox, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Pageof 33

Showing results (271-280 of 325) with videos related to

Sort By:
Pageof 33
Blood Cancer Journal|February 5, 2025
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestryCecilia Bonolo de Campos, Chantal E McCabe, Laura A Bruins, et al.
Blood|July 4, 2013
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemiaAlessandra Ferrajoli, Tait D Shanafelt, Cristina Ivan, et al.
Blood|January 12, 2022
Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinibNoelia Purroy, Yuzhou Evelyn Tong, Camilla K Lemvigh, et al.
Blood|October 7, 2020
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapyNikolaos Ioannou, Patrick R Hagner, Matt Stokes, et al.
Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.
Leukemia|April 4, 2024
IκBε deficiency accelerates disease development in chronic lymphocytic leukemiaJessica Bordini, Chiara Lenzi, Michela Frenquelli, et al.
Blood|April 15, 2022
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trialTait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, et al.
The Lancet. Haematology|May 22, 2019
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validationsJacob D Soumerai, Ai Ni, Mohamed Darif, et al.
Blood|November 23, 2018
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenograftsRosalie M Sterner, Reona Sakemura, Michelle J Cox, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Pageof 33